Attitudes toward biotechnology in the European Union.
Public attitudes toward biotechnology in the European Union have been characterized as negative using Eurobarometer data, but so far little attention has been paid to building a robust metric appropriate for emerging public opinion issues which combine high salience with very limited knowledge by the public. On the basis of the general literature about the formation and structure of attitudes and about public perceptions of science, this article presents a new metric and analysis: first, for estimating the level of awareness and knowledge of biotechnology in Europe; second, for assessing the stability and depth of these evaluative perceptions; and third, for exploring the roles of canonical socio-demographic variables, the knowledge variable and general attitudinal schemas for understanding the perceptions of both benefits and risks of biotech applications. The results show the importance of general value orientations or "worldviews" in shaping positive attitudes, and more of these general cognitive schemas should be measured in future research. The same multivariate model was unable to account for a significant percentage of the total variance in the perception of risks, suggesting that new measures are needed to tap this critical area in the acceptance of biotech in Europe.
Fundacion BBVA, Principe de Vergara 51, 28006, Madrid, Spain. rpardo@fbbva.es
Rafael
R
Pardo
Cees
C
Midden
Jon D
JD
Miller
D000328:Adult; D000818:Animals; D030801:Animals, Genetically Modified; D001290:Attitude; D001709:Biotechnology / Q000193:education / Q000331:legislation & jurisprudence / Q000639:trends; D003142:Communication; D005062:European Union; D030841:Food, Genetically Modified; D005818:Genetic Engineering; D005820:Genetic Testing; D006801:Humans; D030821:Plants, Genetically Modified; D011639:Public Opinion; D018570:Risk Assessment / Q000639:trends